1 600 participants from 90 countries converge from 10 to 13 February at the Bologna Congress Center. Eurogin Congress 2027 positions research, prevention and diagnostics of HPV at the center of its program, aiming to bring scientific results closer to clinical practice.
Practical information for Eurogin Congress 2027
The congress runs 10 to 13 February at the Bologna Congress Center. The event structure features scientific sessions, free communications and clinical tracks. The program committee lists Joseph Monsonego as Scientific Committee Chairman and Paolo Giorgi Rossi and Peter Sasieni as Congress Presidents.
Program and session types at Eurogin Congress 2027
Scientific sessions cover the spectrum of HPV infections and related diseases while clinical sessions are designed to translate findings into everyday practice. The event accepts abstracts for posters and oral presentations and publishes an interactive program with session listings on the official site.
Key figures for Eurogin Congress 2027
Official figures indicate 1 600 participants representing 90 countries. The congress program includes over 660 speakers and poster presenters and 725 oral presentations. Those numbers reflect the event’s broad academic and clinical reach within the HPV field.
B2B outreach and engagement at Eurogin Congress 2027
For companies in biotech, diagnostics and pharmaceutical development, define target audiences by therapeutic area and diagnostic application. Prepare a concise technical dossier that highlights clinical data, validation studies or I+D capabilities. Use the program to pinpoint sessions where potential collaborators present and request short meetings around session breaks.
Commercial teams should foreground operational data and potential clinical partnerships. Provide digital material that links directly to publications, regulatory status or product dossiers. Schedule meetings in advance and use short on-site touchpoints to secure follow-ups after the congress.
Closing note and official link
The congress maintains its focus on prevention and diagnostics, areas that continue to drive changes in screening and vaccine strategies. Registrations and program details for Eurogin Congress 2027 are available at http://www.eurogin.com. Arrive with concrete technical material and a list of prioritized contacts to convert scientific interest into actionable collaborations.
